|
Advertisement | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
November 2016 Volume 16 Number 11 | Advertisement | ||||||||||||||||||||||||||||||||||||||||
| In this issue![]() ![]() ![]() ![]()
|
| |||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||
Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis Ken Cadwell p661 | doi:10.1038/nri.2016.100 This article provides a comprehensive overview of the general functions of autophagy in immunity, the interactions between autophagy and immune signalling pathways and the role of autophagy-immune crosstalk in multicellular immune responses and disease. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
Interleukin-33 in health and disease Foo Yew Liew, Jean-Philippe Girard & Heth Roderick Turnquist p676 | doi:10.1038/nri.2016.95 The cytokine interleukin-33 was first identified as an inducer of type 2 immune responses. It has now been shown to have pleiotropic activities on multiple immune cell types and is involved in numerous infectious and inflammatory diseases, as described in this Review. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||||||
Regulation of T cell signalling by membrane lipids Wei Wu, Xiaoshan Shi & Chenqi Xu p690 | doi:10.1038/nri.2016.103 This Review describes the major lipid species found in the plasma membrane of mammalian cells and highlights the importance of these lipids for regulating T cell signalling. Recent studies have shown that drugs modulating the membrane lipid composition in T cells can alter their immune functions — the authors discuss the potential for such lipid-based immunotherapies in autoimmunity and cancer. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
PI3Kδ and primary immunodeficiencies Carrie L. Lucas et al. p702 | doi:10.1038/nri.2016.93 Gain- and loss-of-function mutations in phosphoinositide 3-kinase-δ (PI3Kδ) result in a primary immunodeficiency syndrome termed APDS. Understanding the function of PI3Kδ in adaptive immune responses — from studies of mouse models of these mutations and from patients with APDS — provides new insights on how mutations in PI3Kδ promote immunodeficiencies. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||
![]() |
*2014 Journal Citation Report (Thomson Reuters, 2015) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |
No comments:
Post a Comment